PMID: 9181387May 1, 1997Paper

Interpretive criteria for susceptibility testing of coagulase-negative staphylococci with special reference to netilmicin

Infection
B NeumeisterR Marre

Abstract

Antibiotic susceptibility of 171 isolates of coagulase-negative staphylococci from 66 preterm infants at a neonatal intensive care unit was tested by the microbroth dilution method. Results were interpreted according to DIN as well as according to NCCLS. Because of the bimodal distribution of MIC values within the CNS population tested, results of susceptibility interpretation according to DIN were identical to NCCLS with the exception of netilmicin (NCCLS: 89% susceptibility; DIN: 16% susceptibility). Since netilmicin is frequently used for treatment of infections caused by coagulase-negative staphylococci, this difference may be of clinical significance.

References

Nov 1, 1990·Antimicrobial Agents and Chemotherapy·H OunissiP Courvalin
Apr 1, 1990·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·H MittermayerR Watschinger
Mar 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C J SoussyP Courvalin
Oct 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B NeumeisterP Bartmann

❮ Previous
Next ❯

Citations

May 15, 2002·Diagnostic Microbiology and Infectious Disease·L M DeshpandeUNKNOWN SENTRY Antimicrobial Surveillance Program Participants Group
Mar 21, 2000·International Journal of Antimicrobial Agents·M Y RohaniT Zainuldin
Jul 5, 2011·Polish Journal of Veterinary Sciences·D ChrobakM Binek
Dec 2, 2005·Emerging Infectious Diseases·Jessica M BuckRuth Lynfield
Feb 24, 2006·Emerging Infectious Diseases·Geoffrey W CoombsKeryn J Christiansen
Mar 31, 2010·Emerging Infectious Diseases·Li-Zhong HanYi-Bo Zhang
Jan 9, 2008·FEMS Microbiology Letters·Dacheng WangXuming Deng

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved